This activity features an interprofessional, multidisciplinary panel of experts offering privileged insights on assessing patient candidacy for immunotherapy in advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). The discussion is augmented by case studies highlighting key aspects of risk stratification, staging, and management.
Upon successful completion of this educational activity, participants should be better able to:
Upon completion of this activity, participants should be better able to:
Director, Melanoma and Renal Cancer Team
Seattle Cancer Care Alliance
Associate Professor, Division of Medical Oncology
University of Washington School of Medicine
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, WA
Physician Assistant, Seattle Cancer Care Alliance
Teaching Associate, University of Washington School of Medicine
Physician Assistant, UW Medicine
Seattle, WA
Academic Director, Mohs Dermatologic Surgery Center
Director, Dana Farber High Risk Cancer Clinic
Assistant Professor, Dermatology, Harvard Medical School
Department of Dermatology Brigham and Women’s Faulkner Hospital
Boston, MA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
